查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198211

可吸收聚合物市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Resorbable Polymers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），可吸收聚合物市场的复合年增长率预计将超过 10%。

COVID-19 对市场的影响不容忽视。 此外，预计该市场在预测期内将稳步增长。

主要亮点

  • 推动市场发展的主要因素是医疗行业不断增长的需求。
  • 3D打印设备在医疗行业的应用有望成为市场机遇
  • 亚太地区主导着全球市场，中国和印度等国家/地区的消费量最大。

可吸收聚合物市场趋势

骨科手术主导市场

  • 在预测期内，骨科可能会继续主导可吸收聚合物市场。
  • 可吸收聚合物具有生物相容性、无毒，并具有热塑性、强度、结晶度、降解性和亲水性等特性，这些特性是用于膝关节、脊柱和髋关节的植入物的关键要求。我来了。
  • 此外，可吸收聚合物可以替代传统组件在骨科应用中的使用，因为它们有助于在舒适的环境中组织再生。 这些因素正在推动可吸收聚合物的市场。

亚太地区预计将成为增长最快的市场

  • 由于医疗行业的需求不断增长，亚太地区在预测期内预计将成为可吸收聚合物市场增长最快的地区。
  • 印度、泰国、韩国、马来西亚和台湾等国家/地区医疗旅游的增加预计会增加使用可吸收聚合物製造的各种医疗产品的消费量。
  • 此外，印度和泰国等提供优质且相对便宜的医疗服务的国家预计会增加可吸收聚合物的消费量。
  • 该地区公共医疗体系的改革和私营医疗行业的快速扩张预计也将推动可吸收聚合物市场的发展。

可吸收聚合物市场竞争对手分析

可吸收聚合物市场是分散的。 市场上的主要参与者包括 Ashland、CORBION、KLS Martin Group、Evonik Industries AG 和 Foster Corporation（排名不分先后）。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查先决条件
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 司机
    • 扩大医疗领域的需求
    • 其他司机
  • 约束因素
    • 其他抑製剂
  • 工业价值链分析
  • 波特的五力分析
    • 供应商的议价能力
    • 消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第 5 章市场细分

  • 材料
    • 聚乳酸 (PLA)
    • 聚乙醇酸 (PGA)
    • 聚己内酯 (PCL)
    • PGA/PLA 共聚物
  • 用法
    • 给药
    • 骨科
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 意大利
      • 法国
      • 其他欧洲地区
    • 世界其他地区

第六章竞争格局

  • 併购、合资企业、联合研究、合同
  • 市场份额 (%)**/排名分析
  • 主要参与者采用的策略
  • 公司简介
    • Ashland
    • Biogeneral
    • CORBION
    • Evonik Industries AG
    • Foster Corporation
    • KLS Martin Group
    • Poly-Med Incorporated
    • Teknimed

第七章市场机会与未来趋势

  • 医疗器械3D打印应用实例
  • 其他商业机会
简介目录
Product Code: 61253

The resorbable polymers market is projected to record a CAGR of more than 10% during the forecast period (2022-2027).

The COVID-19 impact on the market has been negligent. Additionally, the market is expected to grow steadily during the forecast period.

Key Highlights

  • The major factor driving the market is growing demand from the medical industry.
  • Applications in 3D printing of devices in the medical industry are expected to act as an opportunity for the market
  • Asia-Pacific dominated the market globally, with the largest consumption seen in countries such as China and India.

Resorbable Polymers Market Trends

Orthopedics to Dominate the Market

  • Orthopedics may continue to dominate the market for resorbable polymers during the forecast period.
  • Resorbable polymers are biocompatible, non-toxic, and have properties such as thermoplasticity, strength, crystallinity, degradation characteristics, and hydrophilicity, which are major requirements of implants used in knee, spine, and hip.
  • In addition, resorbable polymers help in tissue regeneration in a hospitable environment, thereby replacing the use of conventional components in orthopedic applications. This factor is driving the market for resorbable polymers.

Asia-Pacific is Projected to be the Fastest Growing Market

  • Asia-Pacific is projected to be the fastest-growing market for resorbable polymers during the forecast period, owing to the growing demand from the medical industry.
  • An increase in medical tourism in countries such as India, Thailand, South Korea, Malaysia, and Taiwan is expected to increase the consumption of various medical products manufactured using resorbable polymers.
  • In addition, high-quality and relatively low-cost medical services provided in countries such as India and Thailand are expected to increase the consumption of resorbable polymers.
  • Also, changes in public healthcare reforms and a rapidly expanding private healthcare sector in the region are expected to boost the market for resorbable polymers.

Resorbable Polymers Market Competitor Analysis

The resorbable polymer market is fragmented. Some of the prominent players in the market (in no particular order) include Ashland, CORBION, KLS Martin Group, Evonik Industries AG, and Foster Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand from Medical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Other Restraints
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Material
    • 5.1.1 Polylactic Acid (PLA)
    • 5.1.2 Polyglycolic Acid (PGA)
    • 5.1.3 Polycaprolactone (PCL)
    • 5.1.4 PGA/PLA Copolymers
  • 5.2 Application
    • 5.2.1 Drug Delivery
    • 5.2.2 Orthopedics
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Ashland
    • 6.4.2 Biogeneral
    • 6.4.3 CORBION
    • 6.4.4 Evonik Industries AG
    • 6.4.5 Foster Corporation
    • 6.4.6 KLS Martin Group
    • 6.4.7 Poly-Med Incorporated
    • 6.4.8 Teknimed

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Applications in 3D Printing of Devices in Medical Industry
  • 7.2 Other Opportunities